Ratings Tata Chemicals Limited NSE India S.E.

Equities

TATACHEM

INE092A01019

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-04-26 am EDT			5-day change	1st Jan Change
1,122 ^INR	+0.83%		+1.65%	+1.62%

Mar. 21	Tata Chemicals Limited Receives an Order from National Faceless Assessment Centre, Income Tax Department Levying A Penalty	CI
Feb. 29	Tata Chemicals Limited Announces Retirement of Zarir Langran as Executive Director	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company benefits from high valuations in earnings multiples.
The company is highly valued given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Most analysts recommend that the stock should be sold or reduced.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
TATA CHEMICALS LIMITED	+1.62%	3.43B	-
SHIN-ETSU CHEMICAL CO., LTD.	-0.19%	74.89B	B
BASF SE	+0.09%	46.52B	A-
DUPONT DE NEMOURS, INC.	-4.19%	30.82B	C
PIDILITE INDUSTRIES LIMITED	+9.85%	18.19B	B
BRENNTAG SE	-10.05%	11.54B	B
EASTMAN CHEMICAL COMPANY	+6.39%	11.24B	A-
SYENSQO SA/NV	-8.09%	9.73B	-
ASAHI KASEI CORPORATION	+2.79%	9.4B	A-
SRF LIMITED	+6.35%	9.37B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes